From 15 – 19 February 2021, over 80 participants attended the online LENS Machine Learning School. The school, which was targeted towards neutron and muon facilities staff, offered a gateway for beginner and intermediate coders to get into machine learning, providing an overview of modern and traditional machine learning techniques alongside neutron or muon based applications.
This webinar will focus on how neutrons can provide crucial information to study the structure-dynamics-function relationships in macromolecular drug targets and to design successful drug delivery systems.
This webinar will focus on how neutron scattering techniques can elucidate the structures and steps involved in the aggregation mechanisms to provide crucial information to understand and combat these diseases and to develop better medications.
Exploring the possibilities of using CANS in Europe, an Ad-hoc Working Group of LENS has produced a Report on Low Energy Accelerator-driven Neutron Sources. The report gives an overview of the scope and capabilities of this evolving technology, and offers an outlook and recommendations for CANS to supplement the existing ecosystem of neutron sources in Europe.
Join us for the next LENS Webinar, with Dr Genoveva Burca on 11 Feb 2021 at 11am CEST.
The event showcased the key role of European Research Infrastructures in contributing to solve the most urgent global challenges, including energy storage and viral threats.
Join us for the next LENS Webinar, with Rasmus TOFT-PETERSEN to learn about the the various implemented multiplexing concepts at neutron facilities.
Join us for the next live, interactive LENS Webinar, with Thilo PIRLING to know more about the selection and optimization of the different mechanical and optical components of a dedicated stress diffractometer.
Enjoy the replay of this successful webinar and discover how neutron scattering studies can contribute to the fight against pathological microbes.
After a joint position presenting their plan to tackle HE Missions, the ARIE enhanced its cross-border, multidisciplinary collaboration to offer Europe a strong and valid weapon against the present COVID-19 challenge and other potential viral and microbial threats.